Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders

130Citations
Citations of this article
250Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Implicating particular genes in the generation of complex brain and behavior phenotypes requires multiple lines of evidence. The rarity of most high-impact genetic variants typically precludes the possibility of accruing statistical evidence that they are associated with a given trait. We found that the enrichment of a rare chromosome 22q11.22 deletion in a recently expanded Northern Finnish sub-isolate enabled the detection of association between TOP3B and both schizophrenia and cognitive impairment. Biochemical analysis of TOP3β revealed that this topoisomerase was a component of cytosolic messenger ribonucleoproteins (mRNPs) and was catalytically active on RNA. The recruitment of TOP3β to mRNPs was independent of RNA cis-elements and was coupled to the co-recruitment of FMRP, the disease gene product in fragile X mental retardation syndrome. Our results indicate a previously unknown role for TOP3β in mRNA metabolism and suggest that it is involved in neurodevelopmental disorders. © 2013 Nature America, Inc. All rights reserved.

Cite

CITATION STYLE

APA

Stoll, G., Pietiläinen, O. P. H., Linder, B., Suvisaari, J., Brosi, C., Hennah, W., … Palotie, A. (2013). Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders. Nature Neuroscience, 16(9), 1228–1237. https://doi.org/10.1038/nn.3484

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free